Related Experiment Video
Updated: Aug 9, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Engine shutdown: migrastatic strategies and prevention of metastases
Martina Raudenská1, Kateřina Petrláková1, Tamara Juriňáková1
1Department of Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic.
Abstract:
Most cancer-related deaths among patients with solid tumors are caused by metastases. Migrastatic strategies represent a unique therapeutic approach to prevent all forms of cancer cell migration and invasion. Because the migration machinery has been shown to promote metastatic dissemination, successful migrastatic therapy may reduce the need for high-dose cytotoxic therapies that are currently used to prevent the risk of metastatic dissemination. In this review we focus on anti-invasive and antimetastatic strategies that hold promise for the treatment of solid tumors. The best targets for migrastatic therapy would be those that are required by all forms of motility, such as ATP availability, mitochondrial metabolism, and cytoskeletal dynamics and cell contractility.
Insights
Migrastatic strategies offer a novel approach to combat cancer metastasis by targeting cancer cell migration and invasion. This therapeutic avenue may reduce reliance on high-dose chemotherapy for solid tumors.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Cancer metastasis is the primary cause of mortality in solid tumor patients.
- Current treatments often involve high-dose cytotoxic therapies to prevent metastatic spread.
- Migrastatic strategies present a therapeutic alternative by inhibiting cancer cell migration and invasion.
Purpose of the Study:
- To review anti-invasive and antimetastatic strategies for solid tumor treatment.
- To highlight the potential of migrastatic therapies in reducing chemotherapy's role.
- To identify key molecular targets essential for cancer cell motility.
Main Methods:
- Literature review of anti-invasive and antimetastatic strategies.
- Analysis of the role of migration machinery in metastatic dissemination.
- Identification of universal targets for migrastatic therapy.
Main Results:
- Cancer cell migration and invasion are critical drivers of metastasis.
- Migrastatic therapies aim to block these processes, potentially lowering chemotherapy requirements.
- Key targets include ATP availability, mitochondrial metabolism, and cytoskeletal dynamics.
Conclusions:
- Migrastatic strategies hold significant promise for treating solid tumors.
- Targeting universal motility mechanisms offers a broad therapeutic window.
- Further research into these targets could lead to more effective cancer treatments.

